查詢結果分析
來源資料
相關文獻
- Evaluation of a Simplified Staging System for Prognosis of Hepatocellular Carcinoma
- 簡介肝癌的分期系統
- 肝癌的預後評估及分期系統
- 肝癌的成因及危險因子
- 肝癌病患家屬參加教育心理團體成效探討
- N-Acetyltransferase in Healthy Human Liver and Hepatoma Tissues
- Use of Color Ultrasound in Percutaneous Intravascular Ethanol Injection into the Supplying Vessel of a Hepatocellular Carcinoma: Report of a Case
- 小型肝癌併腦部轉移
- Hepatocellular Carcinoma Presenting with Acquired Porphyria: A Case Report and Review of the Literature
- 肝癌的危險因子
頁籤選單縮合
題 名 | Evaluation of a Simplified Staging System for Prognosis of Hepatocellular Carcinoma=以簡化的分期系統評估肝癌之預後 |
---|---|
作 者 | 雷永耀; 邱守苕; 邱仁輝; 龍藉泉; 周嘉揚; 金光亮; 夏振源; 吳秋文; 彭芳谷; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 98:4 1999.04[民88.04] |
頁 次 | 頁248-253 |
分類號 | 416.246 |
關鍵詞 | 分期系統; 肝癌; Hepatocellular carcinoma; Prognosis; Partial hepatectomy; TNM classification; |
語 文 | 英文(English) |
英文摘要 | The current TNM (tumor, nodes, metastases) staging system for human hepatocellular carcinoma (HCC) has been challenged since a new T staging system was proposed to correlate the staging group with patient outcome after curative liver resection. The new T staging system proposed Tl as no vascular invasion, small size (< 5 cm), and solitary tumor. T2 was defined as the presence of one of the following factors: size greater than 5 cm, vascular invasion, or multiple tumors: T3 as the presence of two of the above three factors: and T4, the presence of all three factors. A total of 323 patients undergoing curative partial hepatectomy for HCC were studied. Kaplan-Meier survival analysis was used to evaluate the postoperative outcome. The new T staging showed good correlation between the staging group and patient outcome. The 1-year disease-free survival (DFS) rate and overall survival (OS) rate were 80.0% and 87.8% for stage 1 (n = 115), 67.6% and 81.6% for stage 2 (n = 136), 40.0% and 58.0% for stage 3 (n = 58), and 21.4% and 42.8% for stage 4 (n = 14), respectively. The 3-yeat-DFS rate and OS rate were 61.0% and 64.5% for stage 1, 37.8% and 50.7% for stage 2, 21.4% and 29.8% for stage 3, and 21.4% and 34.3% for stage 4, respectively. When analyzed using the current International Union Against Cancer (UICC) pathologic (p) TNM staging system, the 1-year and 3-year DFS rates were 86.2% and 64.0% for stage I (n = 30), 73.9% and 50.0% for stage 2 (n = 182), and 46.8% and 22.3% for stage 3 (n = 111), respectively. Our results showed that, while both staging systems allow clear stratification of patients into prognostic groups, the modified TNM system is not superior to the UICC pTNM system in predicting survival of HCC patients after curative partial hepatectomv. A larger scale, multicenter study may be needed to test the revised TNM system. |
本系統中英文摘要資訊取自各篇刊載內容。